Clinical Trial Update: Treatment of Patients With Diffuse Large B Cell Lymphoma Who Are Not Suitable for Anthracycline Containing Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating treatment for patients with diffuse large B-cell lymphoma who are not suitable for anthracycline-containing chemotherapy; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: University College, London | Conditions: Diffuse Large B Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2026-03-17